Moderna (Danish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Moderna" in Danish language version.

refsWebsite
Global rank Danish rank
low place
low place
4th place
24th place
2nd place
13th place
low place
low place
210th place
431st place
1st place
1st place
1,248th place
1,899th place
49th place
129th place
1,177th place
157th place
5,225th place
low place
66th place
194th place
220th place
452nd place

acs.org

cen.acs.org

clinicaltrials.gov

cnbc.com

doi.org

  • Fase IIa-forsøg: Den engelske artikel har om fase IIa: "Phase IIa studies are usually pilot studies designed to demonstrate clinical efficacy or biological activity ('proof of concept' studies)", idet de citerer Yuan J, Pang H, Tong T, Xi D, Guo W, Mesenbrink P (2016). "Seamless Phase IIa/IIb and enhanced dose-finding adaptive design". Journal of Biopharmaceutical Statistics. 26 (5): 912-23. doi:10.1080/10543406.2015.1094807. PMC 5025390. PMID 26390951.

ft.com

modernatx.com

nih.gov

ncbi.nlm.nih.gov

  • Fase IIa-forsøg: Den engelske artikel har om fase IIa: "Phase IIa studies are usually pilot studies designed to demonstrate clinical efficacy or biological activity ('proof of concept' studies)", idet de citerer Yuan J, Pang H, Tong T, Xi D, Guo W, Mesenbrink P (2016). "Seamless Phase IIa/IIb and enhanced dose-finding adaptive design". Journal of Biopharmaceutical Statistics. 26 (5): 912-23. doi:10.1080/10543406.2015.1094807. PMC 5025390. PMID 26390951.

pubmed.ncbi.nlm.nih.gov

  • Fase IIa-forsøg: Den engelske artikel har om fase IIa: "Phase IIa studies are usually pilot studies designed to demonstrate clinical efficacy or biological activity ('proof of concept' studies)", idet de citerer Yuan J, Pang H, Tong T, Xi D, Guo W, Mesenbrink P (2016). "Seamless Phase IIa/IIb and enhanced dose-finding adaptive design". Journal of Biopharmaceutical Statistics. 26 (5): 912-23. doi:10.1080/10543406.2015.1094807. PMC 5025390. PMID 26390951.

reuters.com

  • With Wuhan virus genetic code in hand, scientists begin work on a vaccine, Reuters
      "...Fauci’s agency is partnering with U.S. biotech Moderna Inc, which specializes in vaccines based on ribonucleic acid (RNA) - a chemical messenger that contains instructions for making proteins.
      That team hopes to make an RNA vaccine based on one of the crown-like spikes on the surface of the coronavirus that gives the family of viruses their name, an approach that, unlike many vaccines, would not expose people to the virus. ..."

spiegel.de

vg.no

web.archive.org

wikipedia.org

en.wikipedia.org

  • Fase IIa-forsøg: Den engelske artikel har om fase IIa: "Phase IIa studies are usually pilot studies designed to demonstrate clinical efficacy or biological activity ('proof of concept' studies)", idet de citerer Yuan J, Pang H, Tong T, Xi D, Guo W, Mesenbrink P (2016). "Seamless Phase IIa/IIb and enhanced dose-finding adaptive design". Journal of Biopharmaceutical Statistics. 26 (5): 912-23. doi:10.1080/10543406.2015.1094807. PMC 5025390. PMID 26390951.
  • Cross, Ryan (3. april 2020). "Will the coronavirus help mRNA and DNA vaccines prove their worth?". Chemical & Engineering News (en). 98 (14). Hentet 19. maj 2020.